The store will not work correctly when cookies are disabled.
2,3-Dichloro-N-(1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)benzenesulfonamide
ID: ALA4093994
PubChem CID: 137652824
Max Phase: Preclinical
Molecular Formula: C12H9Cl2N5O2S
Molecular Weight: 358.21
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cn1ncc2c(NS(=O)(=O)c3cccc(Cl)c3Cl)ncnc21
Standard InChI: InChI=1S/C12H9Cl2N5O2S/c1-19-12-7(5-17-19)11(15-6-16-12)18-22(20,21)9-4-2-3-8(13)10(9)14/h2-6H,1H3,(H,15,16,18)
Standard InChI Key: LGBRUKKRAJVNMV-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
28.8478 -12.5394 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.2629 -11.8239 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
28.4358 -11.8223 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.9816 -12.2333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.2642 -10.9958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9805 -10.5870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9794 -9.7606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2619 -9.3475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5439 -9.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5485 -10.5917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4680 -13.2191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4642 -14.5577 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.9527 -13.8904 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.6785 -14.2992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6847 -13.4759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9760 -13.0606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2606 -13.4674 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.2582 -14.2939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9675 -14.7054 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.7169 -15.3452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6961 -11.0017 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
30.6952 -9.3461 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 2 1 0
2 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
11 15 1 0
14 12 1 0
12 13 1 0
13 11 2 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
12 20 1 0
16 4 1 0
6 21 1 0
7 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 358.21 | Molecular Weight (Monoisotopic): 356.9854 | AlogP: 2.47 | #Rotatable Bonds: 3 |
Polar Surface Area: 89.77 | Molecular Species: ACID | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 5.71 | CX Basic pKa: 0.96 | CX LogP: 2.15 | CX LogD: 1.27 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.78 | Np Likeness Score: -2.37 |
References
1. Miah AH, Champigny AC, Graves RH, Hodgson ST, Percy JM, Procopiou PA.. (2017) Identification of pyrazolopyrimidine arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists., 25 (20): [PMID:28801066] [10.1016/j.bmc.2017.07.052] |